The weight loss pill Meridia may increase the risk of heart attacks, according to a company-sponsored study, and is set for review by the FDA next week. Read the full story

This week on WLS News, we’ll explain how calorie counts on fast food menus could curb the obesity epidemic, and why weight loss surgery is becoming increasingly popular Down Under — despite protests from the nation’s major insurance carriers. Plus, find out how much exercise is needed per day for women to maintain their weight, and see why obesity may be under-diagnosed in America. Get the details on all of these stories and more in this week’s newscast. Read the full story

Lap-Band surgery may become a more common treatment option for teens struggling with obesity if proposed regulatory changes are approved. Read the full story

This week on WLS News, get the details on a new study exploring treatment options for diabetes, and find out what it takes to qualify. We’ll also tell you about a change to FDA standards that could make gastric banding a more common treatment option for teens suffering from obesity. Plus, mark your calendars for three upcoming weight loss surgery conferences, and find out how researchers are transforming human fat into valuable stem cells. All of these stories and more in this week’s report! Read the full story

Weight loss pills are awaiting final approval from the FDA.  Lorcaserin and Contrave have shown to curb patient’s eating and have led to double-digit weight loss in early clinical trials. Read the full story

Meridia is being investigated by the FDA for increasing cardiovascular problems in some of it’s users. Read the full story

This week on WLS News, find out what one university is doing to fight obesity on campus — and how the school’s efforts could prevent a group of college seniors from graduating. Plus, get a closer look at a controversial weight loss pill that’s under scrutiny by the Food and Drug Administration – and not for the first time. Also, hear more about a new device that can improve the outcomes for gastric banding surgery. Read the full story

Obesity Drug, Empatic, tested well in clinical trials, but the company still has to make it past the FDA. Watch to find out more on this week’s WLS News. Read the full story